Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.
Department of Ophthalmology, Rambam Health Care Campus, affiliated with the Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; and.
Cornea. 2023 Sep 1;42(9):1110-1115. doi: 10.1097/ICO.0000000000003109. Epub 2022 Aug 10.
The purpose of this study was to assess long-term stability and outcomes of femtosecond astigmatic keratotomy (FSAK) after treatment of high postkeratoplasty astigmatism.
This retrospective study included patients who underwent FSAK for high astigmatism (≥4 D) after penetrating keratoplasty or deep anterior lamellar keratoplasty. Main outcome measures were corneal astigmatism, uncorrected visual acuity, and best-corrected visual acuity (BCVA) at 1 month and 1, 5, and 10 years.
Overall, 61 eyes of 61 patients (mean age 56 ± 19 years, 54.1% male) were included in this study. Preoperative corneal astigmatism ranged from 4 to 25 D. One month after FSAK, mean corneal astigmatism was significantly reduced from 9.02 ± 3.97 D to 4.86 ± 3.10 D ( P < 0.001). Thereafter, corneal astigmatism remained stable at all visits up to 10 years ( P < 0.05 for all compared with baseline). After FSAK, there was a significant improvement in logMAR uncorrected visual acuity from 1.21 ± 0.48 to 0.87 ±0.54 ( P < 0.001) and logMAR BCVA from 1.03 ± 0.55 to 0.49 ± 0.45 ( P < 0.001) which remained stable up to 10 years. A mild reduction in BCVA improvement was seen between 1 month and 1 year.
Femtosecond astigmatic keratotomy was effective and stable at reducing very high magnitudes of postkeratoplasty astigmatism over the long term. The procedure also had a stable effect on visual acuity, albeit some reduction in the degree of BCVA improvement was seen over the early postoperative period.
本研究旨在评估飞秒散光角膜切开术(FSAK)治疗穿透性角膜移植术后或深层角膜层间角膜移植术后高散光的长期稳定性和结果。
本回顾性研究纳入了因高散光(≥4 D)而行 FSAK 的患者。主要观察指标为术后 1 个月、1 年、5 年和 10 年的角膜散光、未矫正视力和最佳矫正视力(BCVA)。
本研究共纳入 61 例 61 眼患者(平均年龄 56±19 岁,54.1%为男性)。术前角膜散光范围为 4 至 25 D。FSAK 术后 1 个月,平均角膜散光从 9.02±3.97 D 显著降低至 4.86±3.10 D(P<0.001)。此后,在 10 年的随访中,角膜散光一直保持稳定(与基线相比,所有时间点均 P<0.05)。FSAK 后,对数视力矫正未矫正视力从 1.21±0.48 显著提高至 0.87±0.54(P<0.001),对数视力矫正 BCVA 从 1.03±0.55 提高至 0.49±0.45(P<0.001),且在 10 年内保持稳定。术后 1 个月至 1 年,BCVA 改善程度略有下降。
FSAK 治疗穿透性角膜移植术后或深层角膜层间角膜移植术后的高散光,长期效果确切、稳定。该手术对视力也有稳定的效果,尽管术后早期 BCVA 改善程度略有下降。